GlaxoSmithKline PLC
LSE:GSK

Watchlist Manager
GlaxoSmithKline PLC Logo
GlaxoSmithKline PLC
LSE:GSK
Watchlist
Price: 1 824.5 GBX 0.19% Market Closed
Market Cap: 74.1B GBX

Wall Street
Price Targets

GSK Price Targets Summary
GlaxoSmithKline PLC

Wall Street analysts forecast GSK stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GSK is 1 824.02 GBX with a low forecast of 1 212 GBX and a high forecast of 2 646 GBX.

Lowest
Price Target
1 212 GBX
34% Downside
Average
Price Target
1 824.02 GBX
0% Downside
Highest
Price Target
2 646 GBX
45% Upside
GlaxoSmithKline PLC Competitors:
Price Targets
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
5% Upside
3613
Beijing Tong Ren Tang Chinese Medicine Co Ltd
32% Upside
1093
CSPC Pharmaceutical Group Ltd
33% Upside
603520
Zhejiang Starry Pharmaceutical Co Ltd
52% Upside
603566
Pulike Biological Engineering Inc
34% Upside
WEED
Canopy Growth Corp
57% Upside
600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
5% Upside
VENUSREM
Venus Remedies Ltd
60% Downside

Revenue
Forecast

Revenue Estimate
GlaxoSmithKline PLC

For the last 13 years the compound annual growth rate for GlaxoSmithKline PLC's revenue is 1%. The projected CAGR for the next 4 years is 5%.

1%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
GlaxoSmithKline PLC

For the last 13 years the compound annual growth rate for GlaxoSmithKline PLC's operating income is 0%. The projected CAGR for the next 4 years is 12%.

0%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
GlaxoSmithKline PLC

For the last 13 years the compound annual growth rate for GlaxoSmithKline PLC's net income is -5%. The projected CAGR for the next 4 years is 16%.

-5%
Past Growth
16%
Estimated Growth
Estimates Accuracy
55%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GSK's stock price target?
Price Target
1 824.02 GBX

According to Wall Street analysts, the average 1-year price target for GSK is 1 824.02 GBX with a low forecast of 1 212 GBX and a high forecast of 2 646 GBX.

What is GlaxoSmithKline PLC's Revenue forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for GlaxoSmithKline PLC's revenue is 1%. The projected CAGR for the next 4 years is 5%.

What is GlaxoSmithKline PLC's Operating Income forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for GlaxoSmithKline PLC's operating income is 0%. The projected CAGR for the next 4 years is 12%.

What is GlaxoSmithKline PLC's Net Income forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for GlaxoSmithKline PLC's net income is -5%. The projected CAGR for the next 4 years is 16%.

Back to Top